{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T12:26:43Z","timestamp":1750249603906},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T00:00:00Z","timestamp":1345075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s10753-012-9525-7","type":"journal-article","created":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T10:02:36Z","timestamp":1345024956000},"page":"110-120","source":"Crossref","is-referenced-by-count":31,"title":["Intrahepatic Expression of Programmed Death-1 and its Ligands in Patients with HBV-Related Acute-on-Chronic Liver Failure"],"prefix":"10.1007","volume":"36","author":[{"given":"Dayan","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoning","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhunyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,16]]},"reference":[{"key":"9525_CR1","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2009.127","volume":"6","author":"RT Stravitz","year":"2009","unstructured":"Stravitz, R.T., and D.J. Kramer. 2009. Management of acute liver failure. Nature Reviews. Gastroenterology & Hepatology 6: 542\u2013553.","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"key":"9525_CR2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1172\/JCI18114","volume":"112","author":"PA Marsden","year":"2003","unstructured":"Marsden, P.A., Q. Ning, L.S. Fung, X. Luo, Y. Chen, M. Mendicino, A. Ghanekar, J.A. Scott, T. Miller, C.W. Chan, M.W. Chan, W. He, R.M. Gorczynski, D.R. Grant, D.A. Clark, M.J. Phillips, and G.A. Levy. 2003. The Fgl2\/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. The Journal of Clinical Investigation 112: 58\u201366.","journal-title":"The Journal of Clinical Investigation"},{"key":"9525_CR3","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/j.1440-1746.2006.04362.x","volume":"22","author":"Q Liu","year":"2007","unstructured":"Liu, Q., Z. Liu, T. Wang, Q. Wang, X. Shi, and W. Dao. 2007. Characteristics of acute and sub-acute liver failure in China: nomination, classification and interval. Journal of Gastroenterology and Hepatology 22: 2101\u20132106.","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"9525_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399401002812","volume":"2001","author":"M Liu","year":"2001","unstructured":"Liu, M., C.W. Chan, I. McGilvray, Q. Ning, and G.A. Levy. 2001. Fulminant viral hepatitis: molecular and cellular basis, and clinical implications. Expert Reviews in Molecular Medicine 2001: 1\u201319.","journal-title":"Expert Reviews in Molecular Medicine"},{"key":"9525_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","volume":"11","author":"H Nishimura","year":"1999","unstructured":"Nishimura, H., M. Nose, H. Hiai, N. Minato, and T. Honjo. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11: 141\u2013151.","journal-title":"Immunity"},{"key":"9525_CR6","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/70932","volume":"5","author":"H Dong","year":"1999","unstructured":"Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nature Medicine 5: 1365\u20131369.","journal-title":"Nature Medicine"},{"key":"9525_CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","volume":"2","author":"Y Latchman","year":"2001","unstructured":"Latchman, Y., C.R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A.J. Long, J.A. Brown, R. Nunes, E.A. Greenfield, K. Bourque, V.A. Boussiotis, L.L. Carter, B.M. Carreno, N. Malenkovich, H. Nishimura, T. Okazaki, T. Honjo, A.H. Sharpe, and G.J. Freeman. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nature Immunology 2: 261\u2013268.","journal-title":"Nature Immunology"},{"key":"9525_CR8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1126\/science.291.5502.319","volume":"291","author":"H Nishimura","year":"2001","unstructured":"Nishimura, H., T. Okazaki, Y. Tanaka, K. Nakatani, M. Hara, A. Matsumori, S. Sasayama, A. Mizoguchi, H. Hiai, N. Minato, and T. Honjo. 2001. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291: 319\u2013322.","journal-title":"Science"},{"key":"9525_CR9","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/nm955","volume":"9","author":"T Okazaki","year":"2003","unstructured":"Okazaki, T., Y. Tanaka, R. Nishio, T. Mitsuiye, A. Mizoguchi, J. Wang, M. Ishida, H. Hiai, A. Matsumori, N. Minato, and T. Honjo. 2003. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nature Medicine 9: 1477\u20131483.","journal-title":"Nature Medicine"},{"key":"9525_CR10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir, M.E., M.J. Butte, G.J. Freeman, and A.H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annual Review of Immunology 26: 677\u2013704.","journal-title":"Annual Review of Immunology"},{"key":"9525_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.20022235","volume":"198","author":"Y Iwai","year":"2003","unstructured":"Iwai, Y., S. Terawaki, M. Ikegawa, T. Okazaki, and T. Honjo. 2003. PD-1 inhibits antiviral immunity at the effector phase in the liver. The Journal of Experimental Medicine 198: 39\u201350.","journal-title":"The Journal of Experimental Medicine"},{"key":"9525_CR12","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1016\/j.febslet.2005.09.098","volume":"579","author":"H Jun","year":"2005","unstructured":"Jun, H., S.K. Seo, H.Y. Jeong, H.M. Seo, G. Zhu, L. Chen, and I.H. Choi. 2005. B7-H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK). FEBS Letters 579: 6259\u20136264.","journal-title":"FEBS Letters"},{"key":"9525_CR13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D.L., E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, A.H. Sharpe, G.J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682\u2013687.","journal-title":"Nature"},{"key":"9525_CR14","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1053\/j.gastro.2008.03.037","volume":"134","author":"Z Zhang","year":"2008","unstructured":"Zhang, Z., J.Y. Zhang, E.J. Wherry, B. Jin, B. Xu, Z.S. Zou, S.Y. Zhang, B.S. Li, H.F. Wang, H. Wu, G.K. Lau, Y.X. Fu, and F.S. Wang. 2008. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B. Gastroenterology 134: 1938\u20131949.","journal-title":"Gastroenterology"},{"key":"9525_CR15","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/hep.22419","volume":"48","author":"A Evans","year":"2008","unstructured":"Evans, A., A. Riva, H. Cooksley, S. Phillips, S. Puranik, A. Nathwani, S. Brett, S. Chokshi, and N.V. Naoumov. 2008. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion. Hepatology 48: 759\u2013769.","journal-title":"Hepatology"},{"key":"9525_CR16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/08820130903062210","volume":"38","author":"Z Xie","year":"2009","unstructured":"Xie, Z., Y. Chen, S. Zhao, Z. Yang, X. Yao, S. Guo, C. Yang, L. Fei, X. Zeng, B. Ni, and Y. Wu. 2009. Intrahepatic PD-1\/PD-L1 up-regulation closely correlates with inflammation and virus replication in patients with chronic HBV infection. Immunological Investigations 38: 624\u2013638.","journal-title":"Immunological Investigations"},{"key":"9525_CR17","doi-asserted-by":"crossref","first-page":"e1001347","DOI":"10.1371\/journal.ppat.1001347","volume":"7","author":"Y Chen","year":"2011","unstructured":"Chen, Y., S. Wu, G. Guo, L. Fei, S. Guo, C. Yang, X. Fu, and Y. Wu. 2011. Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection. PLoS Pathogens 7: e1001347.","journal-title":"PLoS Pathogens"},{"key":"9525_CR18","doi-asserted-by":"crossref","unstructured":"Li H, Wang C, Guo G, Gao C, Wu Y, Chen Y. 2012. The characteristic expression of B7-associated proteins in Langerhans cell sarcoma. Acta Histochemica 114:733\u2013743.","DOI":"10.1016\/j.acthis.2011.12.010"},{"key":"9525_CR19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/82_2010_116","volume":"350","author":"HT Jin","year":"2011","unstructured":"Jin, H.T., R. Ahmed, and T. Okazaki. 2011. Role of PD-1 in regulating T-cell immunity. Current Topics in Microbiology and Immunology 350: 17\u201337.","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"9525_CR20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","volume":"236","author":"LM Francisco","year":"2010","unstructured":"Francisco, L.M., P.T. Sage, and A.H. Sharpe. 2010. The PD-1 pathway in tolerance and autoimmunity. Immunology Reviews 236: 219\u2013242.","journal-title":"Immunology Reviews"},{"key":"9525_CR21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1084\/jem.20030242","volume":"198","author":"T Shin","year":"2003","unstructured":"Shin, T., G. Kennedy, K. Gorski, H. Tsuchiya, H. Koseki, M. Azuma, H. Yagita, L. Chen, J. Powell, D. Pardoll, and F. Housseau. 2003. Cooperative B7-1\/2 (CD80\/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor. The Journal of Experimental Medicine 198: 31\u201338.","journal-title":"The Journal of Experimental Medicine"},{"key":"9525_CR22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.193.7.839","volume":"193","author":"SY Tseng","year":"2001","unstructured":"Tseng, S.Y., M. Otsuji, K. Gorski, X. Huang, J.E. Slansky, S.I. Pai, A. Shalabi, T. Shin, D.M. Pardoll, and H. Tsuchiya. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. The Journal of Experimental Medicine 193: 839\u2013846.","journal-title":"The Journal of Experimental Medicine"},{"key":"9525_CR23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm0902-1039c","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong, H., S.E. Strome, D.R. Salomao, H. Tamura, F. Hirano, D.B. Flies, P.C. Roche, J. Lu, G. Zhu, K. Tamada, V.A. Lennon, E. Celis, and L. Chen. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nature Medicine 8: 793\u2013800.","journal-title":"Nature Medicine"},{"key":"9525_CR24","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1398-9995.2010.02458.x","volume":"66","author":"AK Singh","year":"2011","unstructured":"Singh, A.K., P. Stock, and O. Akbari. 2011. Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy 66: 155\u2013162.","journal-title":"Allergy"},{"key":"9525_CR25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2893.2009.01172.x","volume":"17","author":"T Watanabe","year":"2010","unstructured":"Watanabe, T., A. Bertoletti, and T.A. Tanoto. 2010. PD-1\/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection. Journal of Viral Hepatitis 17: 453\u2013458.","journal-title":"Journal of Viral Hepatitis"},{"key":"9525_CR26","first-page":"1015","volume":"21","author":"ML Rio del","year":"2008","unstructured":"del Rio, M.L., L. Buhler, C. Gibbons, J. Tian, and J.I. Rodriguez-Barbosa. 2008. PD-1\/PD-L1, PD-1\/PD-L2, and other co-inhibitory signaling pathways in transplantation. Transplant International 21: 1015\u20131028.","journal-title":"Transplant International"},{"key":"9525_CR27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2011.10.020","volume":"56","author":"SW Ma","year":"2012","unstructured":"Ma, S.W., X. Huang, Y.Y. Li, L.B. Tang, X.F. Sun, X.T. Jiang, Y.X. Zhang, J. Sun, Z.H. Liu, W.G. Abbott, Y.H. Dong, N.V. Naoumov, and J.L. Hou. 2012. High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B. Journal of Hepatology 56: 775\u2013781.","journal-title":"Journal of Hepatology"},{"key":"9525_CR28","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/hep.23936","volume":"52","author":"B Raziorrouh","year":"2010","unstructured":"Raziorrouh, B., W. Schraut, T. Gerlach, D. Nowack, N.H. Gr\u00fcner, A. Ulsenheimer, R. Zachoval, M. W\u00e4chtler, M. Spannagl, J. Haas, H.M. Diepolder, and M.C. Jung. 2010. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function. Hepatology 52: 1934\u20131947.","journal-title":"Hepatology"},{"issue":"9","key":"9525_CR29","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1073\/pnas.0931259100","volume":"100","author":"P Loke","year":"2003","unstructured":"Loke, P., and J.P. Allison. 2003. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells. Proceedings of the National Academy of Sciences of the United States of America 100(9): 5336\u20135341.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9525_CR30","doi-asserted-by":"crossref","first-page":"9223","DOI":"10.1128\/JVI.71.12.9223-9230.1997","volume":"71","author":"JW Ding","year":"1997","unstructured":"Ding, J.W., Q. Ning, M.F. Liu, A. Lai, J. Leibowitz, K.M. Peltekian, E.H. Cole, L.S. Fung, C. Holloway, P.A. Marsden, H. Yeger, M.J. Phillips, and G.A. Levy. 1997. Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. Journal of Virology 71: 9223\u20139230.","journal-title":"Journal of Virology"},{"key":"9525_CR31","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.176.3.689","volume":"176","author":"C Li","year":"1992","unstructured":"Li, C., L.S. Fung, S. Chung, A. Crow, N. Myers-Mason, M.J. Phillips, J.L. Leibowitz, E. Cole, C.A. Ottaway, and G. Levy. 1992. Monoclonal anti-prothrombinase (3D4.3) prevents mortality from murine hepatitis virus infection (MHV-3). The Journal of Experimental Medicine 176: 689\u2013697.","journal-title":"The Journal of Experimental Medicine"},{"key":"9525_CR32","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/sj.ki.5000345","volume":"70","author":"XH Qin","year":"2006","unstructured":"Qin, X.H., V.W. Lee, Y.P. Wang, G.P. Zheng, Y. Wang, S.I. Alexander, and D.C. Harris. 2006. A protective role for programmed death 1 in progression of murine adriamycin nephropathy. Kidney International 70: 1244\u20131250.","journal-title":"Kidney International"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-012-9525-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-012-9525-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-012-9525-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T15:49:34Z","timestamp":1594568974000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-012-9525-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,16]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["9525"],"URL":"https:\/\/doi.org\/10.1007\/s10753-012-9525-7","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,16]]}}}